Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJung, H.
dc.contributor.authorGonzalez, H.
dc.contributor.authorRodriguez, J.M.
dc.description.abstractThe USP dissolution test was used to select seven products with a wide range of dissolution characteristics for in vivo examination. The bioequivalence of seven (500 mg) products was evaluated in two crossover urinary excretion experiments. In each study three products were compared with the innovator product (Negram-Winthrop-Breon) in 12 subjects according to a 4x4 latin square design. Significantly different, lower bioavailability was observed in two products in relation to that of the innovator product. Linear in vitro-in vivo correlations were found between the cumulative amount excreted at 24 h and the log of the amount dissolved at 30 min and between log of the cumulative amount excreted up to 24 h and the log of the amount dissolved at 45 min.
dc.titleBioequivalence study of nalidixic acid tablets: In vitro-in vivo correlation
dc.relation.ispartofjournalBiopharmaceutics and Drug Disposition
dc.subject.keywordBioequivalence; In vitro-in vivo correlations; Nalidixic acid; USP dissolution test
dc.contributor.affiliationJung, H., Universidad de Guadalajara, Guadalajara, Jal, Mexico; Gonzalez, H., Universidad de Guadalajara, Guadalajara, Jal, Mexico; Rodriguez, J.M., Universidad de Guadalajara, Guadalajara, Jal, Mexico
Appears in Collections:Producción científica UdeG

Files in This Item:
There are no files associated with this item.

Items in RIUdeG are protected by copyright, with all rights reserved, unless otherwise indicated.